Ashwani Mehta
About
In The Last Decade
Ashwani Mehta
25 papers receiving 175 citations
Peers
Comparison fields: 5 of 54
- Surgery 111
- Cardiology and Cardiovascular Medicine 83
- Epidemiology 29
- Pulmonary and Respiratory Medicine 24
- Radiology, Nuclear Medicine and Imaging 24
Countries citing papers authored by Ashwani Mehta
This map shows the geographic impact of Ashwani Mehta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ashwani Mehta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ashwani Mehta more than expected).
Fields of papers citing papers by Ashwani Mehta
This network shows the impact of papers produced by Ashwani Mehta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ashwani Mehta. The network helps show where Ashwani Mehta may publish in the future.
Co-authorship network of co-authors of Ashwani Mehta
This figure shows the co-authorship network connecting the top 25 collaborators of Ashwani Mehta. A scholar is included among the top collaborators of Ashwani Mehta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ashwani Mehta. Ashwani Mehta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 1 | |
| 5 | 1 | |
| 6 | 3 | |
| 7 | 2 | |
| 8 | 2 | |
| 9 | 3 | |
| 10 | 0 | |
| 11 | 1 | |
| 12 | 6 | |
| 13 | 20 | |
| 14 | 0 | |
| 15 | 9 | |
| 16 | 3 | |
| 17 | 1 | |
| 18 | Intravenous Adenosine Infusion is Safe and Well Tolerated During Coronary Fractional Flow Reserve Assessment in Elderly Patients With Severe Aortic Stenosis. | 18 |
| 19 | 7 | |
| 20 | Safety and efficacy of indigenously developed and manufactured bivalirudin in moderate/high-risk Indian patients undergoing percutaneous coronary intervention: the Bivaflo Registry. | 0 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.